Article Tools CASE REPORTS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/PO.22.00625 JCO Precision Oncology no. 7 (2023) e2200625. Published online April 13, 2023. PMID: 37053537 Nodular Regenerative Hyperplasia of the Liver Associated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor in a Patient With Metastatic Renal Cell Carcinoma Shannon Rudolph, BS1xShannon RudolphSearch for articles by this author; Mingjia Li , MD2xMingjia LiSearch for articles by this author; Jinesh Gheeya , MD, PhD2xJinesh GheeyaSearch for articles by this author; Danielle Zimmerman , MD2xDanielle ZimmermanSearch for articles by this author; Ming Yin, MD2xMing YinSearch for articles by this author; Steven K. Clinton, MD, PhD2xSteven K. ClintonSearch for articles by this author; Anil V. Parwani, MD, PhD, MBA3xAnil V. ParwaniSearch for articles by this author; and Yuanquan Yang , MD, PhD2xYuanquan YangSearch for articles by this author Show More 1The College of Medicine, The Ohio State University, Columbus, OH2Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH3Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH https://doi.org/10.1200/PO.22.00625 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologySUPPORTNational Cancer Institute grant K12CA133250 to Y. Y.AUTHOR CONTRIBUTIONSConception and design: Ming Yin, Yuanquan YangAdministrative support: Steven K. ClintonCollection and assembly of data: Shannon Rudolph, Mingjia Li, Jinesh Gheeya, Danielle Zimmerman, Anil V. ParwaniData analysis and interpretation: Shannon Rudolph, Mingjia Li, Jinesh Gheeya, Steven K. ClintonManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Ming YinStock and Other Ownership Interests: NovavaxSteven K. ClintonResearch Funding: NIH, American Institute for Cancer Research, American Cancer Society, Department of Defense-Prostate Cancer Research Program, United States Department of Agriculture, The National Cattleman's Beef AssociationYuanquan YangStock and Other Ownership Interests: PfizerConsulting or Advisory Role: The whiteoak groupSpeakers' Bureau: AstraZenecaResearch Funding: Incyte (Inst), Novartis (Inst), Amgen (Inst)No other potential conflicts of interest were reported.